Precision intervention of cell type-specific targeting is required for future cancer immunotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Precision intervention of cell type-specific targeting is required for future cancer immunotherapy ; volume:2 ; number:6 ; year:2023 ; pages:553-554 ; extent:02
Medical Review ; 2, Heft 6 (2023), 553-554 (gesamt 02)
- Urheber
-
Cai, Yitong
Zhang, Anli
Lu, Changzheng
- DOI
-
10.1515/mr-2022-0037
- URN
-
urn:nbn:de:101:1-2023021013165744425627
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cai, Yitong
- Zhang, Anli
- Lu, Changzheng
Ähnliche Objekte (12)
Targeting the hemangioblast with a novel cell type-specific enhancer
Fibrin-Targeting Immunotherapy for Dementia
Targeting STAT3 in Cancer Immunotherapy
Targeting adenosine for cancer immunotherapy
Targeting neoantigens for cancer immunotherapy
Targeting CD47 for cancer immunotherapy
Immunotherapy targeting esophageal cancer stem cells
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
Precision Glycodendrimers for DC‐SIGN Targeting **
Leveraging CAR macrophages targeting c-Met for precision immunotherapy in pancreatic cancer: insights from single-cell multi-omics
Targeting cytomegalovirus (CMV) antigens for GBM immunotherapy
AIT (allergen immunotherapy): a model for the “precision medicine”
Targeting the hemangioblast with a novel cell type-specific enhancer
Fibrin-Targeting Immunotherapy for Dementia
Targeting STAT3 in Cancer Immunotherapy
Targeting adenosine for cancer immunotherapy
Targeting neoantigens for cancer immunotherapy
Targeting CD47 for cancer immunotherapy
Immunotherapy targeting esophageal cancer stem cells
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
Precision Glycodendrimers for DC‐SIGN Targeting **
Leveraging CAR macrophages targeting c-Met for precision immunotherapy in pancreatic cancer: insights from single-cell multi-omics
Targeting cytomegalovirus (CMV) antigens for GBM immunotherapy
AIT (allergen immunotherapy): a model for the “precision medicine”
Targeting the hemangioblast with a novel cell type-specific enhancer
Fibrin-Targeting Immunotherapy for Dementia
Targeting STAT3 in Cancer Immunotherapy
Targeting adenosine for cancer immunotherapy
Targeting neoantigens for cancer immunotherapy
Targeting CD47 for cancer immunotherapy
Immunotherapy targeting esophageal cancer stem cells
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
Precision Glycodendrimers for DC‐SIGN Targeting **
Leveraging CAR macrophages targeting c-Met for precision immunotherapy in pancreatic cancer: insights from single-cell multi-omics
Targeting cytomegalovirus (CMV) antigens for GBM immunotherapy